ABOUT MIAS PHARMA

MIAS Licensing Framework & QP Services.

MIAS Pharma Ltd was set up  in 2016 to enable Pharma / Bio-Pharma companies to manufacture and import products into the EU / EEA in a compliant manner, at optimal cost, with no significant investment in licence application activities or office / personnel costs.

MIAS Pharma delivers two main solutions:

A licensing framework to enable pharmaceutical importation and batch certification (required before each batch of a medicine can be made available in the EU/EEA marketplace)

Qualified Person (QP) services to oversee the release of investigational medicinal product for Clinical Trials and commercial product to the market.

MIAS Pharma can also provide oversight of:

  • European Qualified Person (QP) services
  • Regulatory compliance of manufacturing activities
  • Regulatory compliance of Analytical Testing and Retesting
  • Regulatory compliance of Repackaging / Relabelling services
  • Regulatory compliance of Shipment and Transportation activities
  • Compliance with responsibilities as a Market Authorisation Holder (MAH)

QP SERVICE SUPPORTS

Supporting QP Services & Quality of your products in the marketplace.

KEY BENEFITS OF WORKING WITH MIAS

The MIAS Advantage

Time to market: 2-4 month lead time v typical 9-12 month lead time to develop a PQS and obtain authorisation.
Cost savings: Outsourcing EU quality function (including QP activity) v employing EU Quality team.
Insights and Expertise: Our CEO is a former senior inspector with the Irish Competent Authority (HPRA) and is considered a Thought Leader in the area of EU GMP and GDP compliance.
Measured growth: Ability to scale up your European operations following proof of concept.

YOUR TRUSTED PARTNER FOR MARKET ACCESS

Authorisations

hpra ie logo

Awards and Nominations

mias pharma awards

MIAS PHARMA OFFICES

Request a Free Consultation Today!